Propranolol Treatment of Infantile Hemangiomas: Anticipatory Guidance for Parents and Caretakers

Pediatric Dermatology

How to Cite

Martin, K., Bleib, F., Chamlin, S. L., Chiu, Y. E., Frieden, I. J., Frommelt, P. C., Garzon, M. C., Kwon, E.-K. M., MacLellan-Tobert, S., Mancini, A. J., Seefeldt, M., Sidbury, R., Siegel, D. H., Drolet, B. A. and Boucek, R. J. (2013), Propranolol Treatment of Infantile Hemangiomas: Anticipatory Guidance for Parents and Caretakers. Pediatric Dermatology, 30: 155–159. doi: 10.1111/pde.12022

Author Information

1. ¹

   Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin

2. ²

   Departments of Pediatrics and Dermatology, Northwestern University, Chicago, Illinois

3. ³

   Department of Cardiology, Seattle Children's Hospital, Seattle, Washington

4. ⁴

   Department of Pediatric Cardiology, Medical College of Wisconsin, Milwaukee, Wisconsin

5. ⁵

   Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin

6. ⁶

   Department of Hematology and Oncology, Vascular Birthmark Institute of New York, New York, New York

7. ⁷

   Department of Dermatology and Pediatrics, University of California at San Francisco, San Francisco, California

8. ⁸

   Department of Dermatology and Pediatrics, Columbia University, New York, New York

9. ⁹

   Department of Cardiology, Gunderson Lutheran Hospital, La Crosse, Wisconsin

10. ¹⁰

    Department of Dermatology, Children's Hospital of Wisconsin, Milwaukee, Wisconsin

11. ¹¹

    Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington

^*Address correspondence to Kari L. Martin, M.D., Medical College of Wisconsin, 8701 Watertown Plank Road, TBRC, 2nd Floor, Suite 2010, Milwaukee, WI 53226, or e-mail: klmartin@mcw.edu.

Publication History

1. Issue published online: 15 JAN 2013
2. Article first published online: 15 JAN 2013